Clinical characteristics of progressive nonarteritic anterior ischemic optic neuropathy.
disc edema
nonarteritic anterior ischemic optic neuropathy
optic neuropathy
visual field defect
Journal
International journal of ophthalmology
ISSN: 2222-3959
Titre abrégé: Int J Ophthalmol
Pays: China
ID NLM: 101553860
Informations de publication
Date de publication:
2021
2021
Historique:
received:
18
04
2020
accepted:
16
09
2020
entrez:
20
4
2021
pubmed:
21
4
2021
medline:
21
4
2021
Statut:
epublish
Résumé
To study whether patients with progressive nonarteritic anterior ischemic optic neuropathy (NAION) present earlier than patients with stable NAION and to describe their clinical characteristics and visual outcome. This was a retrospective chart review. All patients with NAION seen during the acute stage from January 2012 to December 2018 were reviewed. Patients were included if they had documented disc edema and follow up of at least 3mo. Patients with progressive NAION were identified if they worsened in 2 out of 3 parameters: visual acuity ≥3 Snellen lines; Color vision ≥4 Ishihara plates; the visual field defect involved a new quadrant. The clinical characteristics, time from symptom onset to presentation, systemic risk factors and visual outcome were compared to patients with stable NAION. Totally 122 NAION cases met the inclusion criteria. Mean age was 58.1y (range 22-74), 70% were men. Twenty cases (16.4%) had progressive NAION. Patients with progressive NAION did not differ from stable NAION in their demographics, systemic risk factors or in their initial visual deficit. At last follow up, median visual acuity was 1.0 logMAR (IQR 0.64-1.55) in patients with progressive NAION, We find no identifiable risk factors associated with progressive NAION. Progressors arrive earlier for ophthalmological evaluation.
Identifiants
pubmed: 33875941
doi: 10.18240/ijo.2021.04.06
pii: ijo-14-04-517
pmc: PMC8025159
doi:
Types de publication
Journal Article
Langues
eng
Pagination
517-522Informations de copyright
International Journal of Ophthalmology Press.
Références
J Neuroophthalmol. 1994 Mar;14(1):38-44
pubmed: 8032479
Curr Opin Neurol. 2019 Feb;32(1):124-130
pubmed: 30418196
Am J Ophthalmol. 1988 Aug 15;106(2):199-203
pubmed: 3400763
Graefes Arch Clin Exp Ophthalmol. 2016 Oct;254(10):2043-2048
pubmed: 27510295
Am J Ophthalmol. 2018 Nov;195:8-15
pubmed: 30055153
Eye (Lond). 2018 Aug;32(8):1353-1358
pubmed: 29695760
J Neurol Neurosurg Psychiatry. 1990 Oct;53(10):830-3
pubmed: 2266361
Brain. 1991 Feb;114 ( Pt 1A):155-80
pubmed: 1998880
Curr Eye Res. 2017 Jul;42(7):1079-1084
pubmed: 28632028
Arch Ophthalmol. 1997 Nov;115(11):1403-7
pubmed: 9366670
Eye (Lond). 2015 Jan;29(1):65-79
pubmed: 24993324
Am J Ophthalmol. 1988 Oct 15;106(4):443-9
pubmed: 3177563
JAMA. 1995 Feb 22;273(8):625-32
pubmed: 7844872
Am J Ophthalmol. 1983 Oct;96(4):478-83
pubmed: 6624829
N Engl J Med. 2015 Jun 18;372(25):2428-36
pubmed: 26083207
Arch Ophthalmol. 1985 Aug;103(8):1136-42
pubmed: 4026642
Am J Ophthalmol. 1994 Dec 15;118(6):766-80
pubmed: 7977604
Arch Ophthalmol. 1989 Dec;107(12):1743-54
pubmed: 2597065
Invest Ophthalmol Vis Sci. 1992 Oct;33(11):3162-8
pubmed: 1399422
Ophthalmology. 2008 Feb;115(2):298-305.e2
pubmed: 17698200
Br J Ophthalmol. 1974 Dec;58(12):990-1008
pubmed: 4376418
Prog Retin Eye Res. 2009 Jan;28(1):34-62
pubmed: 19063989
Ophthalmology. 2016 Dec;123(12):2446-2455
pubmed: 27659545
Ophthalmology. 2018 Oct;125(10):1623-1627
pubmed: 29705054
J Neuroophthalmol. 1994 Jun;14(2):66-9
pubmed: 7951929
Eye Brain. 2017 Sep 27;9:23-28
pubmed: 29033621
Br J Ophthalmol. 1974 Dec;58(12):981-9
pubmed: 4376417
Ophthalmology. 2005 Jun;112(6):1098-103
pubmed: 15885780
Urology. 2017 Jul;105:76-84
pubmed: 28336289